Clinical Trial Update: Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients. [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study evaluating low molecular weight heparin to prevent recurrent arteriovenous graft thrombosis in chronic hemodialysis pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Dr. Sidney Ben Chetrit | Conditions: Hemodialysis Patients | Phase 4 | Status: UNKNOWN